Trial Profile
An Early Access Programme (EAP) for ATL-1102 in the European Union for treatment of Multiple Sclerosis
Status:
Planning
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 28 May 2015
Price :
$35
*
At a glance
- Drugs ATL 1102 (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 28 May 2015 New trial record